Skip to main content
Equibles
MBX logo

MBX · MBX Biosciences, Inc.

Track MBX — free

Use MBX with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about MBX

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$68.57 +1.49 (+2.22%) At close · Aug 14
Market Cap
$3.30B
Shares
48.16M

MBX Biosciences, Inc. Earnings Call Transcripts

Every quarterly earnings call for MBX Biosciences, Inc. (MBX) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.

Earnings call
FY26 · Q2
2026-08-06
MBX Biosciences, Inc. Q2 FY2026 Earnings Call
Diluted EPS
$-0.78
Audio Transcript Slides 8-K10-Q
Capital Markets Day
Investor event
2026-06-12
MBX Virtual Investor Event: Once-Weekly Canvuparatide Presentations at ENDO 2026
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-06-03
Jefferies Global Healthcare Conference
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-05-11
MBX Biosciences, Inc. Q1 FY2026 Earnings Call
Diluted EPS
$-0.50
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-03-12
MBX Biosciences, Inc. Q4 FY2025 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Conference
Investor event
2026-03-11
Barclays 28th Annual Global Healthcare Conference
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY25 · Q3
2025-11-24
MBX Biosciences, Inc. Q3 FY2025 Earnings Call
Confident tone Phase 2 VAIL Trial Topline Results Canbuperatide / Once-Weekly PTH Therapy Open-Label Extension / Durability
Diluted EPS
$-0.63
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-09-22
MBX Biosciences, Inc. Q2 FY2025 Earnings Call
Confident tone Once-weekly dosing differentiation Open-label extension durability Phase 2 AVAIL trial efficacy results
Diluted EPS
$-0.58
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-12
MBX Biosciences, Inc. Q1 FY2025 Earnings Call
Diluted EPS
$-0.71
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-03-17
MBX Biosciences, Inc. Q4 FY2024 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-07
MBX Biosciences, Inc. Q3 FY2024 Earnings Call
Diluted EPS
$-2.78
Audio Transcript Slides 8-K10-Q
Showing 1–11 of 11 earnings calls
Key facts CIK 1776111 CUSIP 55287L101 13F (30d) 175 filings 171 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)